{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:59:31Z","timestamp":1778767171386,"version":"3.51.4"},"reference-count":0,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,8,1]]},"DOI":"10.1136\/bjo.2008.149674","type":"journal-article","created":{"date-parts":[[2009,5,9]],"date-time":"2009-05-09T00:14:38Z","timestamp":1241828078000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":31,"title":["Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements"],"prefix":"10.1136","volume":"93","author":[{"given":"A R","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L V D.","family":"Priore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2009,5,7]]},"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo.2008.149674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T21:15:48Z","timestamp":1601068548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo.2008.149674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,7]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2009,7,24]]},"published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1136\/bjo.2008.149674","relation":{},"ISSN":["0007-1161"],"issn-type":[{"value":"0007-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5,7]]}}}